Proactive Investors - Run By Investors For Investors

Motif Bio to present three iclaprim posters at industry conference in San Francisco next month

The three posters will contain data on Motif Bio’s lead product, a next-generation antibiotic
bacteria
US regulators want more liver toxicity data before they approve iclamprim

UK biopharma Motif Bio PLC (LON:MTFB) is to present three posters on its iclaprim next-generation antibiotic at an upcoming industry conference in San Francisco.

The American Society for Microbiology (ASM) Microbe 2019 meeting runs from 20 to 24 June. Motif bosses will be presenting their posters on 21 and 22 June.

READ: Motif bosses meet with FDA

AIM- and Nasdaq-listed Motif met with the US Food and Drug Administration (FDA) earlier this month as it looks to secure regulatory approval for iclaprim in patients with acute bacterial skin and skin structure infections (ABSSSI).

The company sought talks after the FDA declined to give the antibiotic the green light, citing in a document the need for additional data on liver toxicity.

As one of Motif’s advisers pointed out, this wasn’t a straight ‘no’. The firm has always said it was keen to discuss potential deficiencies with the information provided.

The latest meeting, which took place on 3 May, offered that chance, with feedback expected within 30 days.

View full MTFB profile View Profile

Motif Bio PLC Timeline

Newswire
May 07 2019

Related Articles

Cameron Durrant
March 04 2019
A goal is to improve the safety of CAR-T therapies, used in the treatment of children with acute lymphoblastic leukemia and adults with advanced lymphomas
seeds in a bowl
March 07 2019
The Vancouver company is developing Omega-3 products as oil, powder or emulsion to be used as food additives
researcher at microscope
May 24 2019
Its lead asset, RXC004, is part of a potentially breakthrough group of cancer drugs called Porcupine inhibitors

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use